News Center
  Home / News

Boryl dioxolan antifungal new drugs-Tavaborole

July 7, 2014 the FDA approved antifungal Tavaborole. Tabavorole is bright ceramide transfer RNA synthetase (Leucyl-transfer RNA synthetase) inhibitor, is the key enzyme of fungal protein synthesis. Clinical use of a 5% solution for the treatment of nail fungus (Onychomycosis). Tavaborole trade name Kerydin, developed by Anacor Pharmaceuticals.
    Tavaborole is the first boron oxygen for the treatment of toenail infections olane (oxaborole) antifungal, Tavaborole indications for toenail fungus Trichophyton rubrum or Trichophyton rubrum infections. Instructions recommended once a day for toenail infections, treatment for 48 weeks, according to the proposal Anacor, and do not need to nail debridement.

 Contact us
在线咨询1 Online Services 1
在线咨询2 Online Services 2
在线咨询3 Online Services 3
  Address: The NO.10 Wing Fai Road, Zhuhai Sanzao Technology Industrial Park,China

COPYRIGHT © 2009-2014 Hairuide Bioscience and Technology Co.,Ltd.  all right reserved.  粤ICP备14010331号 [ Management ]
Tel:0756-3381619   Fax:0756-3381625   Email:876157091@qq.com